SOCS2
Gene Information
- Official Symbol: SOCS2
- Official Name: suppressor of cytokine signaling 2
- Aliases and Previous Symbols: N/A
- Entrez ID: 8835
- UniProt: O14508
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: N/A
- UniProt Summary: SOCS family proteins form part of a classical negative feedback system that regulates cytokine signal transduction. SOCS2 appears to be a negative regulator in the growth hormone/IGF1 signaling pathway. Probable substrate recognition component of a SCF-like ECS (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin- protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins.
Pfam Domains GO Terms
Pfam Domains
| SOCS box |
| SH2 |
GO Terms
| JAK pathway signal transduction adaptor activity |
| growth hormone receptor binding |
| negative regulation of multicellular organism growth |
| 1-phosphatidylinositol-3-kinase regulator activity |
| insulin-like growth factor receptor binding |
| mammary gland alveolus development |
| mammary gland lobule development |
| interleukin-7-mediated signaling pathway |
| negative regulation of receptor signaling pathway via JAK-STAT |
| phosphatidylinositol 3-kinase complex |
| growth hormone receptor signaling pathway |
| negative regulation of receptor signaling pathway via STAT |
| cellular response to growth hormone stimulus |
| cellular response to interleukin-7 |
| response to interleukin-7 |
| negative regulation of insulin receptor signaling pathway |
| response to growth hormone |
| negative regulation of cellular response to insulin stimulus |
| receptor signaling pathway via JAK-STAT |
| receptor signaling pathway via STAT |
| lactation |
| phosphatidylinositol phosphorylation |
| SH3/SH2 adaptor activity |
| regulation of phosphatidylinositol 3-kinase activity |
| regulation of lipid kinase activity |
| regulation of insulin receptor signaling pathway |
| lipid phosphorylation |
| regulation of multicellular organism growth |
| regulation of cellular response to insulin stimulus |
| body fluid secretion |
| regulation of phospholipid metabolic process |
| negative regulation of developmental growth |
| mammary gland development |
| regulation of receptor signaling pathway via JAK-STAT |
| regulation of receptor signaling pathway via STAT |
| response to estradiol |
| phosphatidylinositol metabolic process |
| lipid modification |
| negative regulation of growth |
| cellular response to peptide hormone stimulus |
| glycerophospholipid metabolic process |
| cellular response to peptide |
| regulation of developmental growth |
| post-translational protein modification |
| positive regulation of neuron differentiation |
| phospholipid metabolic process |
| glycerolipid metabolic process |
| response to peptide hormone |
| regulation of lipid metabolic process |
| gland development |
| regulation of cell growth |
| positive regulation of neurogenesis |
| response to peptide |
| regulation of body fluid levels |
| transmembrane receptor protein tyrosine kinase signaling pathway |
| positive regulation of nervous system development |
| positive regulation of cell development |
| cellular response to organonitrogen compound |
| cellular response to hormone stimulus |
| regulation of neuron differentiation |
| cellular response to nitrogen compound |
| regulation of growth |
| cytokine-mediated signaling pathway |
| protein ubiquitination |
| enzyme linked receptor protein signaling pathway |
| protein modification by small protein conjugation |
| regulation of neurogenesis |
| response to lipid |
| regulation of kinase activity |
| organophosphate metabolic process |
| negative regulation of apoptotic process |
| negative regulation of programmed cell death |
| response to hormone |
| response to organic cyclic compound |
| regulation of nervous system development |
| regulation of cell development |
| negative regulation of developmental process |
| cellular lipid metabolic process |
| positive regulation of cell differentiation |
| regulation of transferase activity |
| protein modification by small protein conjugation or removal |
| negative regulation of cell death |
| response to organonitrogen compound |
| cellular response to cytokine stimulus |
| cellular response to oxygen-containing compound |
| response to nitrogen compound |
| response to cytokine |
| secretion |
| negative regulation of multicellular organismal process |
| lipid metabolic process |
| cellular response to endogenous stimulus |
| negative regulation of signal transduction |
| phosphorylation |
| negative regulation of cell communication |
| negative regulation of signaling |
| positive regulation of developmental process |
| response to endogenous stimulus |
| generation of neurons |
| regulation of apoptotic process |
| response to oxygen-containing compound |
| regulation of programmed cell death |
| regulation of phosphorylation |
| negative regulation of response to stimulus |
| neurogenesis |
| positive regulation of signal transduction |
| regulation of cell death |
| intracellular signal transduction |
| positive regulation of multicellular organismal process |
| regulation of phosphate metabolic process |
| regulation of phosphorus metabolic process |
| regulation of cell differentiation |
| positive regulation of cell communication |
| positive regulation of signaling |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
| Screen | Score |
|---|---|
| RK-33 8μM R08 exp518 | -1.9 |
Most Correlated Genes in Chemogenomics
| Gene | Correlation |
|---|---|
| PRIM1 | 0.536 |
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 0/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Essentiality in NALM6
- Essentiality Rank: 12274
- Expression level (log2 read counts): 5.55
Expression Distribution
SOCS2 Expression in NALM6 Cells: 5.55